Cooper Companies (COO) Capital Expenditures (2009 - 2026)
Cooper Companies' (COO) quarterly Capital Expenditures came in at $86.4 million in Q2 2026, up 10.63% year-on-year from $78.1 million in Q2 2025, and down 15.46% quarter-over-quarter from $102.2 million in Q1 2026.
Cooper Companies (COO) Capital Expenditures (2009 - 2026) Analysis & Trends
Cooper Companies' Capital Expenditures history runs 18 years deep, the most recent figure standing at $86.4 million for Q2 2026.
- On a quarterly basis, Capital Expenditures rose 10.63% year-over-year to $86.4 million in Q2 2026; TTM through Apr 2026 was $383.5 million, a 3.28% decrease from a year earlier, with the FY2025 full-year figure at $362.4 million, down 13.96% from the prior year.
- Capital Expenditures fell to $86.4 million in Q2 2026 per COO's latest filing, from $102.2 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $145.0 million in Q4 2023 and bottomed at $43.4 million in Q2 2022.
- The 5-year median for Capital Expenditures is $89.2 million (2024), against an average of $89.3 million.
- Across the five-year window, Capital Expenditures jumped 95.06% in 2023 and tumbled 30.0% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $94.9 million in 2022, then soared by 52.79% to $145.0 million in 2023, then dropped by 3.45% to $140.0 million in 2024, then retreated by 30.0% to $98.0 million in 2025, then declined by 11.84% to $86.4 million in 2026.
- Per Business Quant, the three latest COO Capital Expenditures figures stand at $86.4 million (Q2 2026), $102.2 million (Q1 2026), and $98.0 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 137.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 86.40 Mn |
| Apr 30, 2026 | 86.40 Mn |
| Jan 31, 2026 | 102.20 Mn |
| Jan 31, 2026 | 102.20 Mn |
| Oct 31, 2025 | 98.00 Mn |
| Oct 31, 2025 | 98.00 Mn |
| Jul 31, 2025 | 96.90 Mn |
| Jul 31, 2025 | 96.90 Mn |
| Apr 30, 2025 | 78.10 Mn |
| Apr 30, 2025 | 78.10 Mn |
| Jan 31, 2025 | 89.40 Mn |
| Jan 31, 2025 | 89.40 Mn |
| Oct 31, 2024 | 140.00 Mn |
| Oct 31, 2024 | 140.00 Mn |
| Jul 31, 2024 | 89.00 Mn |
| Jul 31, 2024 | 89.00 Mn |
| Apr 30, 2024 | 74.10 Mn |
| Apr 30, 2024 | 74.10 Mn |
| Jan 31, 2024 | 118.10 Mn |
| Jan 31, 2024 | 118.10 Mn |